As shown in Fig. 1A, expression levels of ProT in early‐stage lung cancer (stage I, n = 15; stage II, n = 3) were higher than those in later‐stage lung cancer (stage III, n = 16; stage IV, n = 4). Here, SLC6A7 is linked to lung carcinoma.